Novartis AG (NVS) is a publicly traded Healthcare sector company. As of September 15, 2026, NVS trades at $137.48 with a market cap of $260.70B and a P/E ratio of 0.00. NVS moved -0.48% today. Year to date, NVS is +0.81%; over the trailing twelve months it is +11.98%. Its 52-week range spans $97.72 to $170.46. Analyst consensus is neutral with an average price target of $159.58. Rallies surfaces NVS's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks NVS insider trades, Form 4 activity, executive purchases, executive sales, shares, prices, and transaction dates when available.
| Metric | Value |
|---|---|
| Price | $137.48 |
| Market Cap | $260.70B |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 4.74% |
| 52-Week High | $170.46 |
| 52-Week Low | $97.72 |
| Volume | 324.53K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $0 |
| Gross Margin | 0.00% |
6 analysts cover NVS: 0 strong buy, 2 buy, 3 hold, 1 sell, 0 strong sell. Consensus rating is neutral. Average price target: $159.58.